These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A neuro-ophthalmological analysis in 80 cases of multiple sclerosis].
    Author: Tsuda H, Ishikawa H, Matsunaga H, Mizutani T.
    Journal: Rinsho Shinkeigaku; 2004 Aug; 44(8):513-21. PubMed ID: 15471086.
    Abstract:
    We report clinical features of ocular symptoms in 80 patients with multiple sclerosis (MS). Serial 80 patients with MS had been admitted to our Neurology Ward at Nihon University Itabashi Hospital from April 1980 to October 2003. All patients were also examined by our neuro-ophthalmologists. Ocular symptoms were observed in 49 patients, and 14 patients were male and 35 were female. Patients' age at onset varied from 17 to 51 years old, with the average being 31.2 +/- 4.2 years. Observation period were 6 months to15 years, and average 5.4 +/- 1.4 years. In visual symptoms, retrobulbar optic neuritis was observed in 33 eyes of 26 patients. On the first attack of retrobulbar optic neuritis, 25 eyes showed a corrected visual acuity of less than 0.1. After corticosteroid therapy, a corrected visual acuity improved more than 1.0 in 17 eyes. Optic atrophy was observed in 22 eyes and color blindness in 16 eyes. On the second attack of retrobulbar optic neuritis on the same eyes, 6 of 9 eyes showed a corrected visual acuity of less than 0.1 after corticosteroid therapy. Optic atrophy and color blindness were confirmed in all eyes. Homonymous hemianopia was detected in 2 female patients and completely resolved after corticosteroid therapy. On the other hand, ocular motor symptoms were observed in 29 patients. Internuclear ophthalmoplegia was detected in 18 patients, nystagmus in 5, abducens nerve palsy in 5, skew deviation in 5, one-and-a-half syndrome in 2, gaze palsy in 2 and ocular myoclonus in 1. In all except one patient with primary position downbeat nystagmus, ocular myoclonus and bilateral internuclear ophthalmoplegia, these symptoms improved completely within 8 weeks after corticosteroid therapy. We emphasize that cooperation of neurologist and ophthalmologist plays an important role for clinical evaluation of MS patients.
    [Abstract] [Full Text] [Related] [New Search]